Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Syndax Pharmaceuticals describes sirtuin modulators for cancer treatment

March 25, 2009

PF-0419789, mutant B-Raf inhibitor, synthesized at Pfizer

March 25, 2009

Rexahn receives FDA approval to begin phase II trials for Archexin in pancreatic cancer

March 25, 2009

Celsion receives orphan drug designation for ThermoDox in liver cancer

March 25, 2009

CD40L gene therapy shows promise in urothelial bladder cancer trial

March 25, 2009

Vertex Pharmaceuticals claims novel protein kinase inhibitors

March 24, 2009

Nereus Pharmaceuticals has begun a phase II trial of NPI-2358 in NSCLC

March 24, 2009

Poniard to focus resources on oncology drug picoplatin

March 23, 2009

Enzon initiates treatment of patients with survivin antagonist EZN-3042 under IND

March 23, 2009

Bristol-Myers Squibb withdraws marketing authorization application for Ixempra

March 23, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...